Susquehanna International Group’s Procept Biorobotics PRCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$828K Sell
33,101
-8,404
-20% -$237K ﹤0.01% 8392
2025
Q4
$1.31M Buy
41,505
+33,408
+413% +$1.11M ﹤0.01% 6577
2025
Q3
$289K Sell
8,097
-54,788
-87% -$2.5M ﹤0.01% 10202
2025
Q2
$3.62M Buy
62,885
+4,805
+8% +$272K ﹤0.01% 4594
2025
Q1
$3.38M Buy
58,080
+27,638
+91% +$1.89M ﹤0.01% 4402
2024
Q4
$2.45M Buy
+30,442
New +$2.6M ﹤0.01% 4857
2024
Q2
Sell
-24,046
Closed -$1.43M 12974
2024
Q1
$1.19M Buy
24,046
+2,726
+13% +$130K ﹤0.01% 6481
2023
Q4
$894K Sell
21,320
-8,398
-28% -$286K ﹤0.01% 7258
2023
Q3
$975K Sell
29,718
-21,015
-41% -$716K ﹤0.01% 6678
2023
Q2
$1.79M Buy
50,733
+39,617
+356% +$1.31M ﹤0.01% 5369
2023
Q1
$316K Buy
11,116
+4,233
+61% +$149K ﹤0.01% 9609
2022
Q4
$286K Sell
6,883
-1,936
-22% -$83.1K ﹤0.01% 9212
2022
Q3
$366K Sell
8,819
-41,420
-82% -$1.65M ﹤0.01% 9303
2022
Q2
$1.64M Buy
+50,239
New +$1.83M ﹤0.01% 5333
2021
Q4
Sell
-5,755
Closed -$220K 13733
2021
Q3
$220K Buy
+5,755
New +$221K ﹤0.01% 11281

Other funds holding PRCT

Susquehanna International Group's PRCT Position: Q1 2026 in Review

Susquehanna International Group reduced its Procept Biorobotics (PRCT) stake by 20% in Q1 2026, selling an estimated $237K and leaving 33,101 shares worth $828K. The position accounts for ﹤0.01% of the portfolio, ranked #8392.

Susquehanna International Group first reported a position in PRCT in Q3 2021 and has held it in 15 quarters since. The position peaked at $3.62M in Q2 2025. 256 funds tracked by Wall St. Rank hold PRCT as of Q1 2026.

  • Susquehanna International Group held 33,101 shares of Procept Biorobotics worth $828K as of Q1 2026.
  • Susquehanna International Group sold 8,404 Procept Biorobotics shares in Q1 2026, an estimated $237K.
  • Procept Biorobotics made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #8392 holding.
  • Susquehanna International Group first reported a position in Procept Biorobotics in Q3 2021 and has held it in 15 quarters since.
  • Susquehanna International Group's Procept Biorobotics position peaked at $3.62M in Q2 2025.
  • 256 funds tracked by Wall St. Rank held Procept Biorobotics as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.